Procyanidin A2, a polyphenol autophagy-enhancer, ameliorates hyperglycemia through multifaceted insulin-related mechanisms

Sci Rep. 2025 Nov 21;15(1):41248. doi: 10.1038/s41598-025-25111-3.

Abstract

Procyanidin A2 (PCA2), a flavonoid from cranberries and lingonberries, has shown various bioactivities, but its antidiabetic effects remain largely under-investigated. This study assessed PCA2's glucose-lowering potential through in silico, in vitro, and in vivo analyses. Molecular docking revealed strong binding of PCA2 to α-glucosidase (PDB: 3TOP), with competitive inhibition (IC₅₀ = 3.62 ± 0.841 µM). PCA2 was non-toxic up to 100 µM in C2C12 and INS-1 cells and enhanced glucose uptake via AMPK/AKT phosphorylation and GLUT4 expression. It also reduced oxidative stress and modulated autophagy-related proteins, increasing Beclin1, LC3-II, and Atg5 while decreasing p62. In diabetic mice, PCA2 improved glucose tolerance, protected β-cells, and restored hepatic and muscular glycogen levels, as confirmed by H&E and PAS staining. Western blotting supported modulation of insulin signaling and autophagy. These findings suggest PCA2 as a promising candidate for functional foods targeting glucose regulation and metabolic dysfunctions.

Keywords: Antidiabetic mechanism; Autophagy; Procyanidin A2; Type 2 diabetes mouse model; Α-Glucosidase.

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Catechin* / chemistry
  • Catechin* / pharmacology
  • Catechin* / therapeutic use
  • Cell Line
  • Diabetes Mellitus, Experimental* / blood
  • Diabetes Mellitus, Experimental* / chemically induced
  • Diabetes Mellitus, Experimental* / drug therapy
  • Diabetes Mellitus, Experimental* / metabolism
  • Functional Food
  • Glucose Transporter Type 4 / metabolism
  • Hyperglycemia* / blood
  • Hyperglycemia* / diet therapy
  • Hyperglycemia* / drug therapy
  • Hyperglycemia* / metabolism
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Insulin* / metabolism
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • Male
  • Mice
  • Mice, Inbred ICR
  • Molecular Docking Simulation
  • Oxidative Stress / drug effects
  • Proanthocyanidins* / chemistry
  • Proanthocyanidins* / pharmacology
  • Proanthocyanidins* / therapeutic use
  • Signal Transduction / drug effects
  • Vaccinium macrocarpon / chemistry
  • Vaccinium vitis-idaea / chemistry
  • alpha-Glucosidases / chemistry
  • alpha-Glucosidases / metabolism

Substances

  • procyanidin A2
  • Proanthocyanidins
  • Catechin
  • alpha-Glucosidases
  • Hypoglycemic Agents
  • Blood Glucose
  • Glucose Transporter Type 4
  • Insulin